Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 329 participants.
Also called NCT02334488
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 329 participants
- Sponsor
- Registry
-
NCT02334488
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Completed
Technical summary
Registry record NCT02334488. Randomized; no masking; primary purpose treatment. Start 2014-12-11 (actual); primary completion 2019-05-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function
- Condition
- Chronic Kidney Disease
- Intervention (Drug)
- Everolimus
- Intervention (Drug)
- Tacrolimus
- Intervention (Drug)
- Mycophenolate sodium
- Lead sponsor
- Poitiers University Hospital
Record details
- Record id
cardio:ct-nct02334488- Content hash
6f372183ef55be45c12497e6124df0fb520c00e0a2bac06c7af296bfba3d6533